Literature DB >> 26752688

Imaging the intratumoral-peritumoral extracellular pH gradient of gliomas.

Daniel Coman1,2, Yuegao Huang1,2, Jyotsna U Rao1,2, Henk M De Feyter1,2, Douglas L Rothman1,2,3, Christoph Juchem1,2,4, Fahmeed Hyder1,2,3.   

Abstract

Solid tumors have an acidic extracellular pH (pHe ) but near neutral intracellular pH (pHi ). Because acidic pHe milieu is conducive to tumor growth and builds resistance to therapy, simultaneous mapping of pHe inside and outside the tumor (i.e., intratumoral-peritumoral pHe gradient) fulfills an important need in cancer imaging. We used Biosensor Imaging of Redundant Deviation in Shifts (BIRDS), which utilizes shifts of non-exchangeable protons from macrocyclic chelates (e.g., 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylene phosphonate) or DOTP(8-) ) complexed with paramagnetic thulium (Tm(3) (+) ) ion, to generate in vivo pHe maps in rat brains bearing 9L and RG2 tumors. Upon TmDOTP(5-) infusion, MRI identified the tumor boundary by enhanced water transverse relaxation and BIRDS allowed imaging of intratumoral-peritumoral pHe gradients. The pHe measured by BIRDS was compared with pHi measured with (31) P-MRS. In normal tissue, pHe was similar to pHi , but inside the tumor pHe was lower than pHi . While the intratumoral pHe was acidic for both tumor types, peritumoral pHe varied with tumor type. The intratumoral-peritumoral pHe gradient was much larger for 9L than RG2 tumors because in RG2 tumors acidic pHe was found in distal peritumoral regions. The increased presence of Ki-67 positive cells beyond the RG2 tumor border suggested that RG2 was more invasive than the 9L tumor. These results indicate that extensive acidic pHe beyond the tumor boundary correlates with tumor cell invasion. In summary, BIRDS has sensitivity to map the in vivo intratumoral-peritumoral pHe gradient, thereby creating preclinical applications in monitoring cancer therapeutic responses (e.g., with pHe -altering drugs).
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  CEST; SPIO; extravasation; magnetic susceptibility; metastasis; permeability

Mesh:

Year:  2016        PMID: 26752688      PMCID: PMC4769673          DOI: 10.1002/nbm.3466

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  49 in total

Review 1.  Dysregulated pH: a perfect storm for cancer progression.

Authors:  Bradley A Webb; Michael Chimenti; Matthew P Jacobson; Diane L Barber
Journal:  Nat Rev Cancer       Date:  2011-08-11       Impact factor: 60.716

Review 2.  Chemical exchange saturation transfer contrast agents for magnetic resonance imaging.

Authors:  A Dean Sherry; Mark Woods
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

Review 3.  pH and therapy of human cancers.

Authors:  J L Evelhoch
Journal:  Novartis Found Symp       Date:  2001

4.  Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites.

Authors:  M L García-Martín; G Hérigault; C Rémy; R Farion; P Ballesteros; J A Coles; S Cerdán; A Ziegler
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

5.  The pH difference between tumor and normal tissue offers a tumor specific target for the treatment of cancer.

Authors:  Leo E. Gerweck
Journal:  Drug Resist Updat       Date:  2000-02       Impact factor: 18.500

Review 6.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

7.  Distribution of temperature changes and neurovascular coupling in rat brain following 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") exposure.

Authors:  Daniel Coman; Basavaraju G Sanganahalli; Lihong Jiang; Fahmeed Hyder; Kevin L Behar
Journal:  NMR Biomed       Date:  2015-08-19       Impact factor: 4.044

Review 8.  Microenvironmental and cellular consequences of altered blood flow in tumours.

Authors:  N Raghunand; R A Gatenby; R J Gillies
Journal:  Br J Radiol       Date:  2003       Impact factor: 3.039

9.  Dendrimer-Based Responsive MRI Contrast Agents (G1-G4) for Biosensor Imaging of Redundant Deviation in Shifts (BIRDS).

Authors:  Yuegao Huang; Daniel Coman; Fahmeed Hyder; Meser M Ali
Journal:  Bioconjug Chem       Date:  2015-11-05       Impact factor: 4.774

Review 10.  Involvement of tumor acidification in brain cancer pathophysiology.

Authors:  Avinash Honasoge; Harald Sontheimer
Journal:  Front Physiol       Date:  2013-11-01       Impact factor: 4.566

View more
  20 in total

1.  Extracellular pH mapping of liver cancer on a clinical 3T MRI scanner.

Authors:  Daniel Coman; Dana C Peters; John J Walsh; Lynn J Savic; Steffen Huber; Albert J Sinusas; MingDe Lin; Julius Chapiro; R Todd Constable; Douglas L Rothman; James S Duncan; Fahmeed Hyder
Journal:  Magn Reson Med       Date:  2019-11-05       Impact factor: 4.668

2.  Towards longitudinal mapping of extracellular pH in gliomas.

Authors:  Yuegao Huang; Daniel Coman; Peter Herman; Jyotsna U Rao; Samuel Maritim; Fahmeed Hyder
Journal:  NMR Biomed       Date:  2016-07-29       Impact factor: 4.044

Review 3.  Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper.

Authors:  Joseph P Erinjeri; Gabriel C Fine; Gosse J Adema; Muneeb Ahmed; Julius Chapiro; Martijn den Brok; Rafael Duran; Stephen J Hunt; D Thor Johnson; Jens Ricke; Daniel Y Sze; Beau Bosko Toskich; Bradford J Wood; David Woodrum; S Nahum Goldberg
Journal:  Radiology       Date:  2019-04-23       Impact factor: 11.105

4.  Extracellular pH Mapping as Therapeutic Readout of Drug Delivery in Glioblastoma.

Authors:  John J Walsh; Fahmeed Hyder
Journal:  Methods Mol Biol       Date:  2022

5.  Molecular Imaging of Extracellular Tumor pH to Reveal Effects of Locoregional Therapy on Liver Cancer Microenvironment.

Authors:  Daniel Coman; Julius Chapiro; Lynn Jeanette Savic; Isabel Theresa Schobert; Dana Peters; John J Walsh; Fabian Max Laage-Gaupp; Charlie Alexander Hamm; Nina Tritz; Luzie A Doemel; MingDe Lin; Albert Sinusas; Todd Schlachter; James S Duncan; Fahmeed Hyder
Journal:  Clin Cancer Res       Date:  2019-10-03       Impact factor: 12.531

6.  Imaging Extracellular Acidification and Immune Activation in Cancer.

Authors:  Fahmeed Hyder; Daniel Coman
Journal:  Curr Opin Biomed Eng       Date:  2021-03-05

7.  The Extension of the LeiCNS-PK3.0 Model in Combination with the "Handshake" Approach to Understand Brain Tumor Pathophysiology.

Authors:  Makoto Hirasawa; Mohammed A A Saleh; Elizabeth C M de Lange
Journal:  Pharm Res       Date:  2022-03-07       Impact factor: 4.580

8.  Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH.

Authors:  Jyotsna U Rao; Daniel Coman; John J Walsh; Meser M Ali; Yuegao Huang; Fahmeed Hyder
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

Review 9.  Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy.

Authors:  Elisabetta Iessi; Mariantonia Logozzi; Davide Mizzoni; Rossella Di Raimo; Claudiu T Supuran; Stefano Fais
Journal:  Metabolites       Date:  2017-12-23

Review 10.  Brain Tumor Diagnostics and Therapeutics with Superparamagnetic Ferrite Nanoparticles.

Authors:  Fahmeed Hyder; S Manjura Hoque
Journal:  Contrast Media Mol Imaging       Date:  2017-12-11       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.